Assignee
SYSTIMMUNE INC
US·13 granted patents·20 pending applications·21 citations·filing 2015–2025
Top patents by PatentIndex Score
33 records- 0190US12029761B2Guidance and Navigation Control proteins and method of making and using thereofSYSTIMMUNE INC·Filed 2019·Granted Jul 9, 2024·6 cites·21 claims
- 0288US11787863B2Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Oct 17, 2023·6 cites·16 claims
- 0387US10919977B2Bispecific tetravalent antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2015·Granted Feb 16, 2021·6 cites·29 claims
- 0478US12384850B2Guidance and navigation control proteins and method of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Aug 12, 2025·1 cites·13 claims
- 0578US11518815B2Anti-ROR1 antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Dec 6, 2022·1 cites·11 claims
- 0673US11560431B2Anti-PD-L1 antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Jan 24, 2023·1 cites·16 claims
- 0772US2026008861A9Anti-4-1bb antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 0872US2025376531A9Anti-4-1bb antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 0970US2026078190A1Bispecific Tetravalent Antibodies and Methods of Making and Using ThereofSYSTIMMUNE INC·Filed 2025·Application pending·0 cites
- 1069US2023322920A1Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 1168US12577325B2Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereofSYSTIMMUNE INC·Filed 2024·Granted Mar 17, 2026·0 cites·46 claims
- 1264US2024279333A1Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 1362US11987635B2Anti-4-1BB antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted May 21, 2024·0 cites·6 claims
- 1460US2025059296A1Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereofSYSTIMMUNE INC·Filed 2022·Application pending·0 cites
- 1559US12428483B2Bispecific tetravalent antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2021·Granted Sep 30, 2025·0 cites·14 claims
- 1659US2025353917A1Egfr binding complex and method of making and using thereofSYSTIMMUNE INC·Filed 2021·Application pending·0 cites
- 1758US2023374157A1Specificy-enhanced bispecific antibody (seba)SYSTIMMUNE INC·Filed 2021·Application pending·0 cites
- 1857US2024309099A1Bispecific tetravalent antibody targeting egfr and her3SYSTIMMUNE INC·Filed 2022·Application pending·0 cites
- 1956US11649286B2Tri-specific antibodiesSYSTIMMUNE INC·Filed 2018·Granted May 16, 2023·0 cites·17 claims
- 2055US2023114801A1MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOFSYSTIMMUNE INC·Filed 2021·Application pending·0 cites
- 2155US2023113563A1Guidance and navigation control (gnc) antibody-like proteinsand methods of making and using thereofSYSTIMMUNE INC·Filed 2021·Application pending·0 cites
- 2255US2025295797A1Ligand-drug conjugate containing hydrophilic sugar structureSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 2355US2024398943A1Methods of treating cancer and the pharmaceutical compositions thereofSYSTIMMUNE INC·Filed 2022·Application pending·0 cites
- 2454US11535667B2Anti-CD3 antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Dec 27, 2022·0 cites·17 claims
- 2553US11466084B2Anti-PD-1 antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Oct 11, 2022·0 cites·16 claims
- 2653US10717783B2Bispecific tetravalent antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2015·Granted Jul 21, 2020·0 cites·18 claims
- 2752US2025205349A1Anti-human trop2 antibody-camptothecin drug conjugate and medical use thereofSYSTIMMUNE INC·Filed 2022·Application pending·0 cites
- 2852US2023365956A1Recombinant ace2-fc fusion molecules and methods of making and using thereofSYSTIMMUNE INC·Filed 2021·Application pending·0 cites
- 2948US2023250410A1Recombinant ace2-fc fusion molecules and methods of making and using thereofSYSTIMMUNE INC·Filed 2021·Application pending·0 cites
- 3045US2023002488A1Guidance and navigation control proteins and method of making and using thereofSYSTIMMUNE INC·Filed 2020·Application pending·0 cites
- 3144US2023086069A1Anti-cd19 antibodies and methods of using and making thereofSYSTIMMUNE INC·Filed 2021·Application pending·0 cites
- 3244US2020347137A1Bispecific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Application pending·0 cites
- 3342US2020157224A1Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SYSTIMMUNE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →